Higher Prevalence of Clinical Cardiovascular Comorbidities in Postmenopausal Women with Self-Reported Premenopausal Hirsutism and/or Oligo-Amenorrhea

    January 2017 in “ Dermato-endocrinology ”
    Fábio Vasconcellos Comim, C S Wippel, Rafaela Martinez Copês, Felipe Welter Langer, J.M. Carvalho, Rafael Noal Moresco, Melissa Orlandin Premaor
    TLDR Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.
    The study conducted in Santa Maria, Brazil, found that postmenopausal women who reported hirsutism and/or oligo-amenorrhea during their reproductive years had a higher prevalence of cardiovascular comorbidities such as angina/myocardial infarction, stroke, and cardiac failure. Additionally, these women were more likely to report chronic obstructive pulmonary disease (COPD) and osteoarthritis. The study highlighted the potential role of hyperandrogenism and associated metabolic disturbances in the development of these comorbidities. The findings suggested that a history of these conditions could be predictive of significant health issues in later life, emphasizing the need for further research to validate these associations.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 24 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

      community Any balding females? I need advice with coping :(

       16 upvotes 8 years ago
      A 27-year-old woman is struggling with hair loss, feeling self-conscious and seeking advice on coping. She mentions trying Minoxidil but is hesitant due to scalp issues and is looking for ways to regain confidence.

    Related Research

    1 / 1 results